Evidence map›Paper›PMID 29259267›Full record

ArticleScientific reports2017

Dysregulation of Mir-196b in Head and Neck Cancers Leads to Pleiotropic Effects in the Tumor Cells and Surrounding Stromal Fibroblasts.

Saúl Álvarez-Teijeiro, Sofía T Menéndez, M Ángeles Villaronga, Juan P Rodrigo, Lorea Manterola, Lucas de Villalaín, Juan C de Vicente, Laura Alonso-Durán, M Pilar Fernández, Charles H Lawrie and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. [Advances in salivary exosomal miRNAs in head and neck squamous carcinoma].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2024
    Review
  8. Article
  9. Review
  10. Article
  11. Hypermethylation-Mediated Silencing ofInternational journal of molecular sciences · 2022
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Regulation of UGT2A1 by miR-196a-5p and miR-196b-5p.The Journal of pharmacology and experimental therapeutics · 2019
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Saúl Álvarez-TeijeiroDepartment of Otolaryngology, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias, IUOPA, University of Oviedo, Oviedo, CIBERONC, Spain.
Sofía T MenéndezDepartment of Otolaryngology, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias, IUOPA, University of Oviedo, Oviedo, CIBERONC, Spain.
M Ángeles VillarongaDepartment of Otolaryngology, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias, IUOPA, University of Oviedo, Oviedo, CIBERONC, Spain.
Juan P RodrigoDepartment of Otolaryngology, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias, IUOPA, University of Oviedo, Oviedo, CIBERONC, Spain.
Lorea ManterolaMolecular Oncology Group, Biodonostia Research Institute, San Sebastián, Spain.
Lucas de VillalaínDepartment of Oral and Maxillofacial Surgery, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias, IUOPA, University of Oviedo, Oviedo, Spain.
Juan C de VicenteDepartment of Oral and Maxillofacial Surgery, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias, IUOPA, University of Oviedo, Oviedo, Spain.
Laura Alonso-DuránDepartment of Otolaryngology, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias, IUOPA, University of Oviedo, Oviedo, CIBERONC, Spain.
M Pilar FernándezDepartment of Biochemistry and Molecular Biology, University of Oviedo, Oviedo, Spain.
Charles H LawrieMolecular Oncology Group, Biodonostia Research Institute, San Sebastián, Spain.
Juana M García-PedreroDepartment of Otolaryngology, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias, IUOPA, University of Oviedo, Oviedo, CIBERONC, Spain. juanagp.finba@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The miR-196 family members have been found dysregulated in different cancers. Therefore, they have been proposed as promising biomarkers and therapeutic targets. This study is the first to investigate the role of miR-196b in the development and progression of head and neck squamous cell carcinomas (HNSCC), and also the impact on the surrounding tumor microenvironment. Increased miR-196b levels were detected in 95% of primary tumors and precancerous lesions, although no significant differences were observed between non-progressing versus progressing dysplasias. Furthermore, increased levels of both miR-196a and miR-196b were successfully detected in saliva samples from HNSCC patients. The functional consequences of altered miR-196 expression were investigated in both HNSCC cell lines and cancer-associated fibroblasts (CAFs) by transfection with specific pre-miR precursors. Results showed that both miR-196a and miR-196b elicit cell-specific responses in target genes and downstream regulatory pathways, and have a distinctive impact on cell proliferation, migration and invasion. These data reveal the early occurrence and prevalence of miR-196b dysregulation in HNSCC tumorigenesis, suggesting its utility for early diagnosis and/or disease surveillance and also as a non-invasive biomarker in saliva. The pleiotropic effects of miR-196a/b in HNSCC cell subpopulations and surrounding CAFs may complicate a possible therapeutic application.

Indexed as

AdultAgedCarcinoma, Squamous CellCell Line, TumorCell ProliferationFemaleFibroblastsGene Expression Regulation, NeoplasticHead and Neck NeoplasmsHumansMaleMicroRNAsMiddle AgedSquamous Cell Carcinoma of Head and NeckTumor MicroenvironmentMicroRNAsMIRN196 microRNA, human

Identifiers

PMID29259267
PMCPMC5736577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.